Globus Medical (GMED) Reports In-Line Q3 EPS

Globus Medical (NYSE: GMED) reported Q3 EPS of $0.29, in-line with the analyst estimate of $0.29. Revenue for the quarter came in at $135.7 million versus the consensus estimate of $139.25 million.

GUIDANCE:

Globus Medical sees FY2016 EPS of $1.20, versus the consensus of $1.20. Globus Medical sees FY2016 revenue of $560 million, versus the consensus of $574.79 million.

For earnings history and earnings-related data on Globus Medical (GMED) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Movano (MOVE) Misses Q2 EPS by 195c
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c